Roberto Debbag

983 total citations
34 papers, 725 citations indexed

About

Roberto Debbag is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Roberto Debbag has authored 34 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 7 papers in Infectious Diseases and 7 papers in Oncology. Recurrent topics in Roberto Debbag's work include Pneumonia and Respiratory Infections (7 papers), Neutropenia and Cancer Infections (7 papers) and Vaccine Coverage and Hesitancy (6 papers). Roberto Debbag is often cited by papers focused on Pneumonia and Respiratory Infections (7 papers), Neutropenia and Cancer Infections (7 papers) and Vaccine Coverage and Hesitancy (6 papers). Roberto Debbag collaborates with scholars based in Argentina, United States and Mexico. Roberto Debbag's co-authors include Eduardo López, Hugo Paganini, Julio A. Vázquez, Lidia Casimir, Pedro Zubizarreta, Raquel Abad, Antonio Latella, Sandra Gómez, Hajime Kamiya and Hannah Christensen and has published in prestigious journals such as Cancer, Journal of Clinical Microbiology and Vaccine.

In The Last Decade

Roberto Debbag

31 papers receiving 696 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberto Debbag Argentina 14 453 274 219 138 101 34 725
Katherine Link United States 6 478 1.1× 137 0.5× 48 0.2× 34 0.2× 194 1.9× 8 774
Lindsay R. Grant United States 22 857 1.9× 237 0.9× 28 0.1× 17 0.1× 225 2.2× 65 1.2k
Jean‐Elie Malkin France 14 547 1.2× 132 0.5× 75 0.3× 11 0.1× 319 3.2× 45 863
Giovanna Orlando Italy 19 442 1.0× 31 0.1× 52 0.2× 40 0.3× 339 3.4× 49 1.1k
Philippe Ovetchkine Canada 18 474 1.0× 105 0.4× 54 0.2× 25 0.2× 304 3.0× 86 900
Aaron Roome United States 10 459 1.0× 29 0.1× 22 0.1× 34 0.2× 77 0.8× 17 772
Constantine Tsigrelis United States 14 195 0.4× 27 0.1× 65 0.3× 58 0.4× 182 1.8× 28 522
Sarah Collins United Kingdom 19 897 2.0× 405 1.5× 18 0.1× 30 0.2× 207 2.0× 33 1.2k
Patricia Holder United States 14 755 1.7× 432 1.6× 18 0.1× 11 0.1× 93 0.9× 20 1.0k
Joaquín Burgos Spain 19 670 1.5× 71 0.3× 67 0.3× 16 0.1× 367 3.6× 82 1.2k

Countries citing papers authored by Roberto Debbag

Since Specialization
Citations

This map shows the geographic impact of Roberto Debbag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Debbag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Debbag more than expected).

Fields of papers citing papers by Roberto Debbag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Debbag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Debbag. The network helps show where Roberto Debbag may publish in the future.

Co-authorship network of co-authors of Roberto Debbag

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Debbag. A scholar is included among the top collaborators of Roberto Debbag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Debbag. Roberto Debbag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Debbag, Roberto, et al.. (2025). Rebuilding vaccine confidence in Latin America and the Caribbean: strategies for the post-pandemic era. Expert Review of Vaccines. 24(1). 581–589. 1 indexed citations
3.
Debbag, Roberto, et al.. (2024). The Impact of Vaccination on COVID-19, Influenza, and Respiratory Syncytial Virus-Related Outcomes: A Narrative Review. Infectious Diseases and Therapy. 14(S1). 63–97. 6 indexed citations
5.
Torres, Jaime R., et al.. (2022). Increasing polio coverage with safer vaccines: a pressing need in Latin America. Revista chilena de infectología. 39(5). 614–622.
6.
Tregnaghi, Miguel, Roberto Debbag, María L. Ávila-Agüero, et al.. (2019). Esquemas de vacunación recomendados para la población de 0 a 18 años de edad. 32(4). 133–144. 1 indexed citations
8.
Abad, Raquel, Eduardo López, Roberto Debbag, & Julio A. Vázquez. (2014). Serogroup W meningococcal disease: global spread and current affect on the Southern Cone in Latin America. Epidemiology and Infection. 142(12). 2461–2470. 63 indexed citations
9.
López, Eduardo Luis & Roberto Debbag. (2012). Enfermedad meningocóccica: siempre presente. Cambios en los serogrupos en el Cono Sur. Revista chilena de infectología. 29(6). 587–594. 16 indexed citations
10.
López, Eduardo, María M Contrini, Alicia Mistchenko, & Roberto Debbag. (2010). LONG-TERM IMMUNITY AFTER TWO DOSES OF INACTIVATED HEPATITIS A VACCINE, IN ARGENTINEAN CHILDREN. The Pediatric Infectious Disease Journal. 29(6). 568–570. 21 indexed citations
11.
Augustovski, Federico, Sebastián García Martí, Andrés Pichón-Rivière, & Roberto Debbag. (2009). Childhood pneumococcal disease burden in Argentina. Revista Panamericana de Salud Pública. 25(5). 423–430. 13 indexed citations
12.
López, Eduardo, et al.. (2007). The cost-effectiveness of universal vaccination of children against hepatitis A in Argentina: results of a dynamic health–economic analysis. Journal of Gastroenterology. 42(2). 152–160. 42 indexed citations
13.
Debbag, Roberto. (2004). Infección por influenza. Riesgos, complicaciones y prevención. Revista Española de Cardiología. 4. 3–6. 2 indexed citations
14.
Paganini, Hugo, et al.. (2004). Análisis clínico y de los factores de riesgo de mortalidad de 86 casos de endocarditis infecciosa en niños y adolescentes en Argentina (1988-2000). Enfermedades Infecciosas y Microbiología Clínica. 22(8). 455–461. 5 indexed citations
15.
Paganini, Hugo, et al.. (2004). Análisis clínico y de los factores de riesgo de mortalidad de 86 casos de endocarditis infecciosa en niños y adolescentes en Argentina (1988-2000). Enfermedades Infecciosas y Microbiología Clínica. 22(8). 455–461. 1 indexed citations
16.
Paganini, Hugo, Sandra Gómez, Silvina Ruvinsky, et al.. (2003). Outpatient, sequential, parenteral‐oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease. Cancer. 97(7). 1775–1780. 72 indexed citations
17.
Paganini, Hugo, Pedro Zubizarreta, Antonio Latella, et al.. (2001). Criterios de bajo riesgo de mortalidad en niños con neutropenia y fiebre durante la quimioterapia por cancer. Medicina-buenos Aires. 2 indexed citations
18.
Paganini, Hugo, et al.. (2001). Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia. Cancer. 91(8). 1563–1567. 58 indexed citations
19.
Paganini, Hugo, et al.. (2000). Oral administration of cefixime to lower risk febrile neutropenic children with cancer. Cancer. 88(12). 2848–2852. 69 indexed citations
20.
Paganini, Hugo, Rosa Bologna, Roberto Debbag, et al.. (1998). Fever and Neutropenia in Children with Cancer in One Pediatric Hospital in Argentina. Pediatric Hematology and Oncology. 15(5). 405–413. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026